Eyecare spin-off Bausch + Lomb files for IPO

Almost 18 months since its parent company announced Bausch + Lomb (B+L) would be spun off as a pure-play eye health company, the entity has filed for an initial public offering (IPO) on the New York and Toronto stock exchanges.
Read More
Nicole Carnt UNSW early career researcher

The rocky path of an early career researcher

After spending the first 10 years of my career as a practising optometrist in Australia and the UK, I returned to Australia in 1999 and seized an opportunity at the Cornea and Contact Lens Unit (now BHVI) where I fell in love with research. I liked following protocols, discovering associations, formulating and presenting data. Read More